Swedish cancer therapy granted

Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Sanionas kokainstudie inledd

Bioteknikföretagets samarbetspartner TRC har påbörjat rekrytering till studien om kokainberoende.

EMA tillsätter expertgrupp mot Zika

Erbjuder rådgivning kring vetenskapliga och regulatoriska frågor till bolag som utvecklar läkemedel och vaccin mot viruset.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Sprint får ny vetenskaplig rådgivare

Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.

535 miljoner till regenerativ medicin

Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Satsar på tidig forskning

Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Här testas tekniker för framtidens tillverkning

Biologiska läkemedel är världens snabbast växande klass av läkemedel. Sverige vill hänga på. Men då räcker det inte med innovativa molekyler. Vi måste bli bra p...

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Raysearch igång i Kina

Första patienten ombord i strålstudie.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Stöd till kvinnliga forskare

17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Första Crispr-bolaget till börsen

Editas Medicine blir det första bolaget på börsen med fokus på det omtalade genmodifieringsverktyget Crispr/Cas9.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Sales Representative, Applied Biosystems

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.